We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$421M
AUM Growth
-$97M
Cap. Flow
-$103M
Cap. Flow %
-24.48%
Top 10 Hldgs %
40.42%
Holding
78
New
4
Increased
9
Reduced
51
Closed
7

Top Buys

Rank Stock Value
1
AON icon
Aon
AON
+$11.4M
2
PEP icon
PepsiCo
PEP
+$6.17M
3
NVS icon
Novartis
NVS
+$6.03M
4
BTI icon
British American Tobacco
BTI
+$4.75M
5
NVO
Novo Nordisk
NVO
+$3.41M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$26.3M
2
MSFT icon
Microsoft
MSFT
+$6.91M
3
BG icon
Bunge Global
BG
+$5.72M
4
MDT icon
Medtronic
MDT
+$5.28M
5
UNP icon
Union Pacific
UNP
+$4.97M

Sector Composition

Rank Sector Weight
1 Healthcare 26.36%
2 Technology 15.78%
3 Industrials 13.89%
4 Financials 12.97%
5 Consumer Staples 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYT
51
DELISTED
Syngenta Ag
SYT
$2.37M 0.56%
29,939
-839
-3% -$67.6K
AN icon
52
AutoNation
AN
$7.37B
$2.19M 0.52%
44,940
-31,060
-41% -$1.44M
KHC icon
53
Kraft Heinz
KHC
$32.4B
$1.61M 0.38%
18,418
– –
WMT icon
54
Walmart Inc
WMT
$900B
$1.38M 0.33%
59,850
– –
UNH icon
55
UnitedHealth
UNH
$389B
$1.24M 0.29%
+7,720
New +$1.15M
VIV icon
56
Telefônica Brasil
VIV
$21B
$1.19M 0.28%
88,882
-3,950
-4% -$52.9K
LHX icon
57
L3Harris
LHX
$56.9B
$1.17M 0.28%
11,430
-39,870
-78% -$3.94M
CPA icon
58
Copa Holdings
CPA
$5.71B
$1.06M 0.25%
11,710
-5,430
-32% -$492K
BDX icon
59
Becton Dickinson
BDX
$45.8B
$1.04M 0.25%
6,458
– –
SNY icon
60
Sanofi
SNY
$109B
$964K 0.23%
23,850
-94,890
-80% -$3.74M
GNTX icon
61
Gentex
GNTX
$5.12B
$935K 0.22%
47,470
-165,530
-78% -$3.01M
ABBV icon
62
AbbVie
ABBV
$465B
$769K 0.18%
12,275
+75
+0.6% +$4.58K
SSL icon
63
Sasol
SSL
$7.03B
$760K 0.18%
26,569
-1,300
-5% -$35.7K
XOM icon
64
ExxonMobil
XOM
$634B
$680K 0.16%
7,537
-2,020
-21% -$177K
MMM icon
65
3M
MMM
$94.1B
$617K 0.15%
4,131
-1,244
-23% -$180K
PG icon
66
Procter & Gamble
PG
$347B
$616K 0.15%
7,325
-1,830
-20% -$156K
ABT icon
67
Abbott
ABT
$187B
$517K 0.12%
13,460
– –
CHL
68
DELISTED
China Mobile Limited
CHL
$508K 0.12%
9,693
-420
-4% -$23.6K
USB icon
69
US Bancorp
USB
$100B
$336K 0.08%
6,533
-1,590
-20% -$75.6K
IBM icon
70
IBM
IBM
$214B
$295K 0.07%
1,862
-680
-27% -$104K
JPM icon
71
JPMorgan Chase
JPM
$950B
$207K 0.05%
2,403
-730
-23% -$55.7K
CAG icon
72
Conagra Brands
CAG
$7.38B
– –
-18,991
Closed -$696K
CVX icon
73
Chevron
CVX
$374B
– –
-4,733
Closed -$487K
ICL icon
74
ICL Group
ICL
$6.76B
– –
-971,757
Closed -$3.79M
MOS icon
75
The Mosaic Company
MOS
$7.34B
– –
-132,711
Closed -$3.25M
1 2
3
4

Similar funds

HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
PAMS
Pinpoint Asset Management (Singapore) Singapore $433M AUM 32.19% 1-Year Est. Return
SSWG
Seven Springs Wealth Group Brentwood, Tennessee $432M AUM 23% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Foyston, Gordon, & Payne's Q4 2016 Portfolio in Review

As of Q4 2016, Foyston, Gordon, & Payne held 78 positions worth $421M, down 19% from $518M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $103M in Q4 2016, closing 7 positions and reducing 51 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $26.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.

Against the trend, Foyston, Gordon, & Payne opened a new position in British American Tobacco worth $4.72M.

  • Foyston, Gordon, & Payne's largest Q4 2016 buy was British American Tobacco: 83,820 shares worth $4.72M.
  • Foyston, Gordon, & Payne added most to Aon in Q4 2016, an estimated $11.4M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2016 reduction was Microsoft, cutting an estimated $6.91M.
  • Foyston, Gordon, & Payne fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $26.3M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 40% of its $421M portfolio in Q4 2016.
  • Foyston, Gordon, & Payne opened 4 new positions and closed 7 in Q4 2016.
  • Foyston, Gordon, & Payne's portfolio value fell 19% quarter-over-quarter to $421M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2016, filed 13 Feb 2017.